Titlebook: Nanobiotechnology in Neurodegenerative Diseases; Mahendra Rai,Alka Yadav Book 2019 Springer Nature Switzerland AG 2019 Alzheimers.parkinso

只看該作者 · 發(fā)表于 2025-3-28 17:05:30

Application of Mycogenic Nanoparticles Against Neurodegenerative Diseases,process, besides the conditions used during the process, such as temperature, pH and substrate concentration. Metal nanoparticles associated with polysaccharides and proteins; depict bioactivity related to treatment of diseases such as neurodegenerative diseases. These nanoparticles are ecologically

只看該作者 · 發(fā)表于 2025-3-28 19:24:44

,Nanobiotechnology in Parkinson’s Disease,ogical fluids, and novel MRI agents for contrast enhancement in imaging applications. Nanotechnology could also revolutionize the PD therapeutic pipeline, which is currently focused on the relief of motor symptoms. To date, the efficacy of nanotechnology in PD treatment has been supported by a large

只看該作者 · 發(fā)表于 2025-3-29 01:38:17

Selenium Nanoparticles as Therapeutic Agents in Neurodegenerative Diseases,context, the selenium nanoparticles play an important role in the application for neurodegenerative diseases. In this chapter, we explain the green synthesis of selenium nanoparticles using eco-friendly methods, their characterization using various analytical techniques and applications in the diagn

只看該作者 · 發(fā)表于 2025-3-29 05:06:48

只看該作者 · 發(fā)表于 2025-3-29 10:23:09

只看該作者 · 發(fā)表于 2025-3-29 12:48:57

Nanocarrier-Mediated Drug Delivery Systems for Neurodegenerative Diseases,larity, and surface chemistry of nanoparticles are the determinants of efficacy in transporting across BBB. Nanocarriers can be designed in such a way that it does not alter the effect of the drugs. However, care has to be taken when choosing nanomaterials (NM) as some are nonbiodegradable. They can

只看該作者 · 發(fā)表于 2025-3-29 16:44:35

,Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease,Lipid-based nanosized drug delivery systems seem to be very promising in delivering the entrapped drug to the brain by virtue of their lipidic nature and small size. Lipid-based nanocarriers have the added advantage of very low cytotoxicity and avoidance of P-glycoprotein-mediated efflux activity of

只看該作者 · 發(fā)表于 2025-3-29 23:27:21

只看該作者 · 發(fā)表于 2025-3-30 01:54:17

只看該作者 · 發(fā)表于 2025-3-30 05:27:40

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 09:02
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved